IL-1β Exacerbates Amyloid Deposition In Islets: A Mechanism for Increased β-Cell Loss in Type 2 Diabetes?

被引：0
|
作者：
Mellati, Mahnaz
Meier, Daniel
Hogan, Meghan F.
Templin, Andrew T.
Kahn, Steven E.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2092-P
引用
收藏
页码：A535 / A535
页数：1
相关论文
共 50 条
  • [1] Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation
    Boni-Schnetzler, Marianne
    Thorne, Jeffrey
    Parnaud, Geraldine
    Marselli, Lorella
    Ehses, Jan A.
    Kerr-Conte, Julie
    Pattou, Francois
    Halban, Philippe A.
    Weir, Gordon C.
    Donath, Marc Y.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 4065 - 4074
  • [2] β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid Deposition
    Jurgens, Catherine A.
    Toukatly, Mirna N.
    Fligner, Corinne L.
    Udayasankar, Jayalakshmi
    Subramanian, Shoba L.
    Zraika, Sakeneh
    Aston-Mourney, Kathryn
    Carr, Darcy B.
    Westermark, Per
    Westermark, Gunilla T.
    Kahn, Steven E.
    Hull, Rebecca L.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (06): : 2632 - 2640
  • [3] Blocking IL-1β in type 2 diabetes
    Solinger, Alan M.
    CYTOKINE, 2010, 52 (1-2) : 10 - 10
  • [4] Role of IL-1β in type 2 diabetes
    Dinarello, Charles A.
    Donath, Marc Y.
    Mandrup-Poulsen, Thomas
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (04) : 314 - 321
  • [5] Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
    Seth L Masters
    Aisling Dunne
    Shoba L Subramanian
    Rebecca L Hull
    Gillian M Tannahill
    Fiona A Sharp
    Christine Becker
    Luigi Franchi
    Eiji Yoshihara
    Zhe Chen
    Niamh Mullooly
    Lisa A Mielke
    James Harris
    Rebecca C Coll
    Kingston H G Mills
    K Hun Mok
    Philip Newsholme
    Gabriel Nuñez
    Junji Yodoi
    Steven E Kahn
    Ed C Lavelle
    Luke A J O'Neill
    Nature Immunology, 2010, 11 : 897 - 904
  • [6] Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
    Masters, Seth L.
    Dunne, Aisling
    Subramanian, Shoba L.
    Hull, Rebecca L.
    Tannahill, Gillian M.
    Sharp, Fiona A.
    Becker, Christine
    Franchi, Luigi
    Yoshihara, Eiji
    Chen, Zhe
    Mullooly, Niamh
    Mielke, Lisa A.
    Harris, James
    Coll, Rebecca C.
    Mills, Kingston H. G.
    Mok, K. Hun
    Newsholme, Philip
    Nunez, Gabriel
    Yodoi, Junji
    Kahn, Steven E.
    Lavelle, Ed C.
    O'Neill, Luke A. J.
    NATURE IMMUNOLOGY, 2010, 11 (10) : 897 - U1501
  • [7] The relationships between macrophage infiltration and amyloid deposition in the islets of humans with type 2 diabetes
    Dhayal, S.
    Richardson, S. J.
    Morgan, N. G.
    DIABETOLOGIA, 2013, 56 : S339 - S339
  • [8] HUMAN TYPE 2 DIABETES IS ASSOCIATED WITH ISLET AMYLOID DEPOSITION, DECREASED β-CELL AREA, AND INCREASED β-CELL APOPTOSIS
    Toukatly, M. N.
    Jurgens, C.
    Kahn, S. E.
    Hull, R. L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 133 - 133
  • [9] The Effects of Amyloid Formation on IL-1 Receptor Antagonist Production in Human Islets
    Hui, Queenie
    Kieffer, Timothy J.
    Ao, Ziliang
    Safikhan, Nooshin
    Asadi, Ali
    Meloche, Mark
    Warnock, Garth L.
    Marzban, Lucy
    DIABETES, 2017, 66 : A570 - A570
  • [10] The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
    Herder, Christian
    Dalmas, Elise
    Boeni-Schnetzler, Marianne
    Donath, Marc Y.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (10): : 551 - 563
12345